DK0445781T3 - Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol - Google Patents

Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol

Info

Publication number
DK0445781T3
DK0445781T3 DK91103425.4T DK91103425T DK0445781T3 DK 0445781 T3 DK0445781 T3 DK 0445781T3 DK 91103425 T DK91103425 T DK 91103425T DK 0445781 T3 DK0445781 T3 DK 0445781T3
Authority
DK
Denmark
Prior art keywords
arylcarbonyl
aminoalkyl
indole
preparations containing
glaucoma
Prior art date
Application number
DK91103425.4T
Other languages
Danish (da)
English (en)
Inventor
Susan Jean Ward
Malcolm Rice Bell
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Application granted granted Critical
Publication of DK0445781T3 publication Critical patent/DK0445781T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91103425.4T 1990-03-08 1991-03-06 Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol DK0445781T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49020190A 1990-03-08 1990-03-08

Publications (1)

Publication Number Publication Date
DK0445781T3 true DK0445781T3 (da) 1996-02-19

Family

ID=23947024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103425.4T DK0445781T3 (da) 1990-03-08 1991-03-06 Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol

Country Status (21)

Country Link
EP (1) EP0445781B1 (fr)
JP (1) JP3157179B2 (fr)
KR (1) KR0183396B1 (fr)
AT (1) ATE133663T1 (fr)
AU (1) AU643757B2 (fr)
CA (1) CA2036307C (fr)
DE (1) DE69116705T2 (fr)
DK (1) DK0445781T3 (fr)
ES (1) ES2082872T3 (fr)
FI (1) FI95369C (fr)
GR (1) GR3019058T3 (fr)
HU (1) HU215125B (fr)
IE (1) IE72953B1 (fr)
IL (1) IL97426A (fr)
MX (1) MX174433B (fr)
MY (1) MY106109A (fr)
NO (1) NO179612C (fr)
NZ (1) NZ237309A (fr)
PH (1) PH27022A (fr)
PT (1) PT96938B (fr)
RU (1) RU2073670C1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
FR2713224B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
FR2714057B1 (fr) * 1993-12-17 1996-03-08 Sanofi Elf Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
ID27812A (id) * 1998-05-01 2001-04-26 Lilly Co Eli ESTER PENGHAMBAT sPLA2
ATE247963T1 (de) * 1998-05-26 2003-09-15 Pfizer Prod Inc Medikament zur behandlung von glaukoma und ischämischer retinopathie
WO2001040183A1 (fr) * 1999-12-03 2001-06-07 Alcon Universal Ltd. 1-aminoalkyl-1 h-indoles pour traiter le glaucome
AU771130B2 (en) * 2000-01-18 2004-03-11 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO2001058869A2 (fr) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Modulateurs de recepteurs aux cannabinoides, leurs procedes de preparation et utilisations de modulateurs de recepteurs aux cannabinoides pour le traitement de maladies respiratoires et non respiratoires
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
AR038966A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
SE0203070D0 (en) * 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
KR20070012389A (ko) * 2004-03-05 2007-01-25 악조 노벨 엔.브이. 칸나비노이드 cb1 수용체의 아고니스트로서의(인돌-3-일)-헤테로시클 유도체
MX2007011142A (es) * 2005-03-12 2007-11-06 Unilever Nv Composiciones para el cuidado del cabello y/o cuero cabelludo que incorporan compuestos de amino-oxo-indol-ilideno.
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
RU2404185C1 (ru) * 2009-04-16 2010-11-20 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) РАВНОМЕРНО МЕЧЕННЫЙ ТРИТИЕМ (R)-(+)-[5-МЕТИЛ-3-(4-МОРФОЛИНИЛМЕТИЛ)-2,3-ДИГИДРО-[1,4]ОКСАЗИНО [2,3,4-hi]-6-ИНДОЛИЛ]-1-НАФТАЛИНИЛМЕТАНОН АЦЕТАТ
JP6025234B1 (ja) * 2016-03-10 2016-11-16 株式会社サンライフ 箸における箸置き形成方法及び箸置き機能を有する箸
CN107628981B (zh) * 2017-10-31 2019-07-30 威海市妇女儿童医院 一种肉桂酰基吲哚啉化合物及其制备青光眼药物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
US4581354A (en) * 1984-08-06 1986-04-08 Sterling Drug Inc. 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
US4634776A (en) * 1984-08-06 1987-01-06 Sterling Drug, Inc. 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
DE3821148A1 (de) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
HUT56492A (en) 1991-09-30
FI911131A0 (fi) 1991-03-06
IL97426A (en) 1996-03-31
NO179612C (no) 1996-11-13
NZ237309A (en) 1993-02-25
KR0183396B1 (ko) 1999-05-01
NO910868D0 (no) 1991-03-05
FI911131L (fi) 1991-09-09
PT96938B (pt) 1998-07-31
FI95369B (fi) 1995-10-13
MX24839A (es) 1993-10-01
EP0445781A1 (fr) 1991-09-11
DE69116705D1 (de) 1996-03-14
IL97426A0 (en) 1992-06-21
JPH04235164A (ja) 1992-08-24
GR3019058T3 (en) 1996-05-31
IE910700A1 (en) 1991-09-11
MX174433B (es) 1994-05-16
NO910868L (no) 1991-09-09
HU215125B (hu) 1998-09-28
EP0445781B1 (fr) 1996-01-31
ATE133663T1 (de) 1996-02-15
RU2073670C1 (ru) 1997-02-20
JP3157179B2 (ja) 2001-04-16
CA2036307C (fr) 2002-07-09
CA2036307A1 (fr) 1991-09-09
AU643757B2 (en) 1993-11-25
NO179612B (no) 1996-08-05
FI95369C (fi) 1996-01-25
IE72953B1 (en) 1997-05-07
ES2082872T3 (es) 1996-04-01
KR910016745A (ko) 1991-11-05
DE69116705T2 (de) 1996-09-26
AU7266991A (en) 1991-09-12
MY106109A (en) 1995-03-31
PT96938A (pt) 1991-10-31
PH27022A (en) 1993-02-01

Similar Documents

Publication Publication Date Title
DK0445781T3 (da) Anti-glaucomapræparater indeholdende 3-arylcarbonyl-1-aminoalkyl-1H-indol
ZA907338B (en) Thienylcarboxylates of amino alcohols
DE69010139D1 (de) Haarkräftigungsmittel.
DK0472327T3 (da) Præparat på form af øjendråber
ATE96671T1 (de) Verwendung von tetrahydrocortisol in der therapie von glaukom.
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE109465T1 (de) 4-aryl-4-piperidine (oder -pyrrolidin- oder - hexahydroazepin-) carbinole und heterocyclische analoga davon.
IT1240683B (it) Composizione farmaceutica contenente egf
DK0437225T3 (da) Topiske præparater
ATE98647T1 (de) Substituierte thieno(2,3-b) thiophen-2sulfonamide als mittel gegen glaukoma.
FR2483234B2 (fr)
DK0579939T3 (da) Phospholipidderivater
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE174911T1 (de) 1-dimethylcarbamoyl-1h-1,2,4-triazole- substituiert in stellungen 3 und 5
ATE60765T1 (de) Pyranderivate.
DE3066521D1 (en) Drug for the local treatment of glaucoma
DE69000877D1 (de) Augenpraeparate enthaltend timolol maleate.